Xenetic Biosciences Inc (XBIO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -307.486 | -17.913 | -43.459 | -100.389 | -62.731 | -34.218 | -37.944 | -32.655 |
Return on Equity (%) | -511.379 | -23.597 | -60.296 | -133.149 | -74.022 | -36.883 | -40.898 | -35.277 |
Return on Invested Capital (%) | -420.069 | -24.051 | -63.872 | -76.193 | -34.22 | -39.992 | -44.964 | -42.289 |
Operating Margin (%) | -1782.533 | -47.37 | N/A | -75147.059 | -3160.412 | -486.219 | -383.831 | -162.795 |
Net Profit Margin (%) | -1941.367 | -47.396 | N/A | -106229.412 | -2492.449 | -486.219 | -383.831 | -162.795 |
Book Value Per Share | 0.312 | 0.15 | -0.215 | 0.901 | 1.06 | 1.134 | 0.76 | 2.928 |
Earnings Per Share | -4.985 | -0.304 | -0.599 | -2.043 | -0.946 | -0.348 | -0.365 | -1.236 |
Cash Per Share | 0.346 | 0.469 | 0.047 | 1.173 | 1.001 | 1.125 | 0.73 | 2.686 |
Working Capital Per Share | 0.554 | 0.334 | -0.033 | 1.095 | 0.993 | 1.067 | 0.701 | 2.624 |
Operating Profit Per Share | 0.257 | 0.642 | N/A | 0.002 | 0.038 | 0.072 | 0.095 | 0.759 |
EBIT Per Share | -4.64 | -0.304 | -0.599 | -1.445 | -1.199 | -0.348 | -0.365 | -1.236 |
EBITDA Per Share | -4.64 | -0.304 | -0.599 | -1.445 | -1.199 | -0.348 | -0.365 | -1.236 |
Free Cash Flow Per Share | -4.987 | -0.306 | -0.601 | -2.044 | -0.948 | -0.348 | -0.337 | -1.236 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 8,41M | 8,72M | 9,4M | 6,07M | 8,75M | 13,44M | 15,17M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 14,32M | 15,17M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -141.419 | N/A | N/A | N/A | -233.855 | N/A |
Net Profit Margin (%) | N/A | N/A | -141.419 | N/A | N/A | N/A | -233.855 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 6,08M |
Ratio cours/bénéfice | -1,47 |
Ratio prix/ventes | 2,39 |
Ratio prix/liquidités | 0,68 |
Ratio prix/valeur comptable | 0,62 |
Rendement de dividende | - |
Actions en circulation | 1,54M |
Volume moyen (1 semaine) | 49,27k |
Volume moyen (1 mois) | 33,24k |
Variation sur 52 semaines | 23,13% |
Plus haut sur 52 semaines | 5,20 |
Plus bas sur 52 semaines | 2,78 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales